These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32333678)

  • 41. Concomitant use of VAQTA with PedvaxHIB and Infanrix in 12 to 17 month old children.
    Petrecz M; Ramsey KP; Stek JE; Martin JC; Klopfer SO; Kuter B; Schödel FP; Lee AW
    Hum Vaccin Immunother; 2016; 12(2):503-11. PubMed ID: 26308112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reactogenicity profile of a combined hepatitis A and B vaccine in clinical practice: a naturalistic study in adult travellers.
    Vilella A; Dal-Ré R; Simó D; Puente J; Díez C; García-Corbeira P; Bayas JM
    Vaccine; 2005 Mar; 23(19):2465-9. PubMed ID: 15752832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation on the effect of immunization and safety of live attenuated and inactivated hepatitis A vaccine in China].
    Li H; Zhang XS; An J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Jan; 34(1):24-7. PubMed ID: 23648244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
    Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
    Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
    Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
    Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Combined (associated) immunization against typhoid, typhus and plague].
    Gapochko KG; Misnikov OP; Kolkov VF; Kekcheeva NG; Semenova BN; Titova TS
    Voen Med Zh; 1994 Apr; (4):42-6, 79. PubMed ID: 8091696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
    Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
    Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
    Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination against hepatitis A in children aged 12 to 24 months [corrected].
    Abarca K; Ibañez I; Flores J; Vial PA; Safary A; Potín M
    Arch Med Res; 2001; 32(5):468-72. PubMed ID: 11578765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
    Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Viral hepatitis: preventable illnesses].
    Baumgarten R
    Z Arztl Fortbild Qualitatssich; 1998 Dec; 92(10):677-80. PubMed ID: 10028595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study.
    Burgess MA; Rodger AJ; Waite SA; Collard F
    Vaccine; 2001 Sep; 19(32):4835-41. PubMed ID: 11535336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An open, prospective, randomized study comparing the immunogenicity and safety of two inactivated hepatitis A pediatric vaccines in toddlers, children and adolescents in China.
    Li RC; Li Y; Yi N; Huang L; Wan Z; Zhang Y; Rasuli A
    Pediatr Infect Dis J; 2013 Feb; 32(2):e77-81. PubMed ID: 23334341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A review of immunogenicity and tolerability of live attenuated Hepatitis A vaccine in children.
    Rao S; Mao JS; Motlekar S; Fangcheng Z; Kadhe G
    Hum Vaccin Immunother; 2016 Dec; 12(12):3160-3165. PubMed ID: 27532370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity and safety of concomitant administration of a combined hepatitis A/B vaccine and a quadrivalent meningococcal conjugate vaccine in healthy adults.
    Alberer M; Burchard G; Jelinek T; Reisinger EC; Meyer S; Forleo-Neto E; Dagnew AF; Arora AK
    J Travel Med; 2015; 22(2):105-14. PubMed ID: 25483566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
    Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Current status of immunization in the Armed Forces: need of continuous adaptation of vaccinations against cerebrospinal meningitis, typhoid and hepatitis A].
    Meyran M; Buisson Y; Desfontaine M
    Ann Gastroenterol Hepatol (Paris); 1994 Oct; 30(5):227-31. PubMed ID: 7802441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.